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Abstract 
Purpose: The aim of the study was to investigate two single nucleotide polymorphisms (SNP) in PTK2 
for associations with human muscle strength phenotypes in healthy men.   
Methods: Measurement of maximal isometric voluntary knee extension (MVCKE) torque, net MVCKE 
torque and vastus lateralis (VL) specific force, using established techniques, was completed on 120 
Caucasian men (age = 20.6 ± 2.3 yr; height = 1.79 ± 0.06 m; mass = 75.0 ± 10.0 kg; mean ± SD).  All 
participants provided either a blood (n = 96) or buccal cell sample, from which DNA was isolated and 
genotyped for the PTK2 rs7843014 A/C and rs7460 A/T SNPs using real-time polymerase chain 
reaction.   
Results: Genotype frequencies for both SNPs were in Hardy-Weinberg equilibrium (X2 ≤ 1.661, P ≥ 
0.436).  VL specific force was 8.3% higher in rs7843014 AA homozygotes than C-allele carriers (P = 
0.017) and 5.4% higher in rs7460 AA homozygotes than T-allele carriers (P = 0.029).  No associations 
between either SNP and net MVCKE torque (P ≥ 0.094) or peak MVCKE torque (P ≥ 0.107) were 
observed.   
Conclusions: These findings identify a genetic contribution to the inter-individual variability within 
muscle specific force and provides the first independent replication, in a larger Caucasian cohort, of an 
association between these PTK2 SNPs and muscle specific force, thus extending our understanding of 
the influence of genetic variation on the intrinsic strength of muscle. 
 
Keywords 
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Abbreviations 
ACSA Anatomical cross-sectional area 
ANCOVA Analysis of covariance 
ANOVA Analysis of variance 
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AVI Audio video interleave 
BMI Body mass index 
CcT Co-activation torque 
DXA Dual energy x-ray absorptiometry 
ECM Extracellular matrix 
EMG Electromyography 
FAK Focal adhesion kinase 
MVCKE Maximal voluntary isometric knee extension 
MVCKF Maximal voluntary isometric knee flexion 
PCSA Physiological cross-sectional area 
PTK2 Protein tyrosine kinase 2 
SNP Single nucleotide polymorphism 
STT Superimposed twitch torque 
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Introduction 
Muscle specific force, defined here as the force per unit cross-sectional area of muscle, represents the 
intrinsic strength of a muscle and is a key determinant of functional capacity and mobility in later life 
which should be maintained (McGregor et al. 2014).  In young, untrained adults muscle specific force 
varies inter-individually by 14-16% (Stebbings et al. 2014; Erskine et al. 2009), which might suggest 
some individuals are predisposed to possessing greater muscle specific force and may therefore be less 
susceptible to experiencing functional declines associated with ageing.  Whilst it is generally accepted 
that differences in the force generating capacity of individual fibres (Bottinelli et al. 1996), 
intramuscular fat and/or connective tissue content (Macaluso et al. 2002; Kent-Braun et al. 2000) 
contribute to this inter-individual variability, it is possible that genetic differences also contribute.  
Accordingly, two single nucleotide polymorphisms (SNPs) of the protein tyrosine kinase 2 gene 
(PTK2), responsible for encoding focal adhesion kinase (FAK), were found to explain ~10% of the 
inter-individual variability in the muscle specific force of untrained individuals (Erskine et al. 2012). 
 
Focal adhesion kinase is an integrin-associated protein tyrosine kinase localised at focal adhesion 
complexes via interactions between its focal adhesion targeting domain and other integrin-associated 
proteins (Hildebrand et al. 1993; Schaller 2001).  Focal adhesion complexes are important components 
of cell costameres, which overlie the Z- and M-lines of myofibres and form regular connections with 
the sarcolemma (Pardo et al. 1983).  Thus, a pathway of force transmission exists by which force can 
be transmitted laterally across adjacent myofibres and the sarcolemma to the extracellular matrix (ECM) 
(Flück et al. 1999; Patel and Lieber 1997; Bloch and Gonzalez-Serratos 2003), via these regular 
connections.  Given the location of costameres, they could effectively split the serial sarcomeres of a 
myofibre into multiple force-generating units to enable this pathway of force transmission to the muscle 
fascia, although this hypothesis is speculative (Jones et al. 1989; Huijing 1999).  Costamere formation 
and turnover is regulated by FAK activity, which is known to increase in hypertrophying muscle (Flück 
et al. 1999).  Similarly, increases in muscle specific force are also observed following skeletal muscle 
hypertrophy (Reeves et al. 2004b), which is thought to be the consequence of an increased costamere 
density (Erskine et al. 2012).  A greater costamere density, that is an increase in the number of 
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intermediate connections between the ECM, myofibre and aponeurosis, may result in an increase in the 
number of force-generating units within a fibre, and thus, whole muscle, without the need for additional 
parallel sarcomeres.  Consequently, the force generated by the muscle fibre and whole muscle would 
be greater despite physiological cross-sectional area (PSCA) remaining constant, thus enhancing muscle 
specific force.  Indeed where alterations to normal costamere function have been observed in dystrophic 
muscle, decreased specific force was attributed to an inferior ability to transmit force laterally due to 
deficiencies in important costameric proteins (Ramaswamy et al. 2011). 
 
The PTK2 rs7843014 and rs7460 polymorphisms, which are in linkage disequilibrium (Erskine et al. 
2012), were recently associated with the level of gene expression and exceptional longevity in a Spanish 
population (Garatachea et al. 2014).  More specifically, the rs7843014 CC and rs7460 TT genotypes 
were tentatively associated with lower PTK2 gene expression whilst being optimal for exceptional 
longevity (Garatachea et al. 2014).  In a population of healthy Caucasian men, however, it was the 
rs7843014 AA and rs7460 AA genotypes that were significantly associated with producing higher 
baseline specific force (Erskine et al. 2012).  The authors speculated that the rs7843014 AA and rs7460 
AA homozygotes had improved lateral force transmission due to an increased costamere density 
compared to C-allele and T-allele carriers respectively (Erskine et al. 2012).  This preliminary report, 
however, involved only a small population (n = 51), therefore independent replications are required to 
confirm these initial observations.   
 
The aim of the current investigation, therefore, was to investigate if the rs7843014 and rs7460 
polymorphisms within the PTK2 gene were associated with skeletal muscle specific force and other 
measures of muscle strength in a larger population of Caucasian men, independent of that done 
previously.  We hypothesized that the rs7843014 AA and rs7460 AA genotypes would be significantly 
associated with higher specific force, maximal isometric voluntary knee extension (MVCKE) torque and 
net MVCKE torque production than C-allele and T-allele carriers respectively. 
 
Methods 
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Participants 
Participants were healthy, unrelated Caucasian men (n = 120, Table 1) who had not undertaken any 
structured training in the preceding 12 months and had not taken part in the aforementioned preliminary 
report (Erskine et al. 2012).  Participants were free from musculoskeletal or neurological disorders, had 
a body mass index (BMI) between 18.5 kg∙m-2 and 30 kg∙m-2 and all gave written consent to participate.  
Habitual physical activity levels were assessed via questionnaire (Baecke et al. 1982) to ensure only 
those participants who undertook less than 3 hours of low-to-moderate habitual work-based and leisure-
time physical activity per week were included in the study.  The Ethics committee of Manchester 
Metropolitan University granted ethical approval and all experimental procedures complied with the 
Declaration of Helsinki.  
 
Knee extension and flexion torque 
Maximal voluntary isometric knee flexion (MVCKF) torque and MVCKE was assessed using an 
isokinetic dynamometer (Cybex Norm, Cybex International Inc., NY, USA) whilst participants were 
seated at 85° hip flexion and secured with straps across the shoulders, waist and right thigh.  Participants 
completed a minimum of three MVCKE and MVCKF contractions at knee joint angles of 70°, 80° and 
90° of knee flexion on the right leg in a randomised order, with 2 min rest between contractions.  The 
knee joint angle at which peak MVCKE torque occurred was considered the optimal angle and was used 
for subsequent measurements of net MVCKE and specific force.  The right limb of each participant was 
selected for assessment as previous investigations using untrained participants have reported no 
significant bilateral differences in MVC torque (Lindle et al. 1997; Hageman et al. 1988; Häkkinen et 
al. 1998), in addition to determinants of this, such as muscle architecture (Kearns et al. 2001), size and 
EMG (Häkkinen et al. 1996). 
 
Muscle activation and co-activation 
Two self-adhesive electrodes (7.5 x 12.5 cm; Tyco Galvanic Pad, Uni-Patch, MN, USA) were 
positioned over the muscle belly of the vastus medialis, rectus femoris and vastus lateralis and 
connected to an external stimulation device (DS7, Digitimer stimulator, Welwyn, Garden City, UK) 
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such that the anode was placed 5-10 cm proximal to the superior border of the patella and the cathode 
was located 5-10 cm distal to the inguinal crease (Place et al. 2010). With the participant at rest, the 
maximal twitch torque stimulation intensity was identified by administering single twitches of 
increasing current intensity until no further increases in twitch torque were observed. The current 
intensity at which no further increases in twitch torque were observed was defined as the supramaximal 
stimulation intensity and this intensity was superimposed during MVCKE to allow for the calculation of 
net MVCKE torque, together with co-activation torque.  Antagonist muscle co-activation during MVCKE 
was determined through electromyographic (EMG) assessment of the biceps femoris.  Two pre-gelled 
Ag-AgCl electrodes (Ambu, Neuroline 720, Denmark) were positioned in the mid-sagittal plane over 
the distal third of the long head of the biceps femoris, with an inter-electrode distance of 20 mm, and a 
reference electrode was positioned over the lateral tibial condyle.  The integral of the root mean square 
EMG activity corresponding to peak MVCKE torque at the optimal knee joint angle was calculated and 
averaged over 0.5 s either side of the instantaneous peak.  EMG activity of the biceps femoris during 
MVCKF was measured and, assuming a linear relationship between torque and EMG activity, was used 
to estimate co-activation torque (Reeves et al. 2004b).  Subsequently, net MVCKE torque was calculated 
as CcT + (MVCKE + STT), where CcT is the co-activation torque and STT is the superimposed twitch 
torque obtained using the interpolated twitch technique.   
 
Muscle architecture 
Vastus lateralis (VL) muscle architecture was assessed in vivo at 50% of muscle length using B-mode 
ultrasonography (AU5, Esaote, Italy) during MVCKE at the predetermined optimum joint angle.  The 
40 mm, 7.5 MHz linear-array probe was placed perpendicular to the skin over an echo-absorptive 
reference marker in the mid-sagittal plane during image acquisition.  Ultrasound scans were recorded 
at a sampling frequency of 25 Hz in audio video interleave (AVI) format and all signals of torque, 
electrical stimuli and EMG activity were displayed on a computer screen, interfaced with an acquisition 
system (AcqKnowledge, Biopac Systems, Santa Barbara, USA), to enable analogue-to-digital 
conversion at a sampling frequency of 2000 Hz.  Single images were captured for measurement of 
pennation angle and fascicle length on a minimum of three fascicles from which the mean was recorded 
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(NIH ImageJ, version 1.44o, National Institute of Health, Bethesda, Maryland).  Measurement of 
fascicle length in all instances required extrapolation of the superficial and deep aponeuroses to allow 
for estimation of fascicle length, due to fascicles extending beyond the ultrasound field of view (Reeves 
and Narici 2003).   
 
Tendon moment arm length 
Patellar tendon moment arm length was measured using a single, low-energy (0.9 μSv) sagittal plane 
dual energy X-ray absorptiometry (DXA) scan (22.6 x 13.7 cm; Hologic Discovery W, Vertec Scientific 
Ltd, UK) (Erskine et al. 2014).  During scanning, each participant lay on their side with the hip flexed 
at 85° and the right knee joint positioned at the previously determined optimum angle using a 
goniometer.  Scans were exported (OsiriX 5.0.2, Pixmeo Sarl, Geneva, Switzerland) and the 
perpendicular distance between the tibiofemoral contact point and the axis of the patellar tendon was 
measured as the patellar tendon moment arm length (Tsaopoulos et al. 2006).  Patellar tendon force was 
calculated by dividing net MVCKE torque by patellar tendon moment arm length.  The contribution of 
the VL to patellar tendon force was estimated using previously reported data (Narici et al. 1992), and 
divided by the cosine of pennation angle to estimate VL fascicle force. 
 
VL muscle size and specific force 
Transverse ultrasound scans were obtained from the medial to lateral muscle border at 50% of VL 
muscle length and recorded in AVI format to assess VL anatomical cross-sectional area (ACSA) 
(Reeves et al. 2004a).  Single scans were contour matched to provide a complete image of VL ACSA, 
which was measured using digitizing software.  Muscle volume was estimated using ACSA, VL muscle 
length and a series of regression-derived constants, as validated previously (Morse et al. 2007).  
Calculation of VL muscle PCSA was achieved by dividing VL muscle volume by fascicle length.  
Ultimately, VL specific force was calculated by dividing VL fascicle force by VL PCSA (Reeves et al. 
2004b). 
 
Blood sampling, DNA isolation and genotyping 
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A 5 mL blood sample was collected from a superficial forearm vein of 96 participants into EDTA tubes 
(BD Vacutainer Systems, Plymouth, UK) and stored at -20°C in 2 mL microcentrifuge tubes (Eppendorf 
AG, Hamburg, Germany).  For 24 participants, buccal cell samples were obtained in duplicate 
(Whatman Sterile OmniSwab, GE Healthcare, USA) following a minimum 1-hour abstinence from food 
and drink, according to the manufacturer’s guidelines.  Each collection tip was ejected into a 2 mL 
microcentrifuge tube and stored at -20°C.   
 
The Qiagen QIAcube spin protocol (Qiagen, Crawley, UK) was completed in accordance with the 
manufacturer’s guidelines using the buffers contained in the Qiagen DNA Blood Mini kit for the 
extraction of genomic DNA from whole blood and buccal samples.  Genotyping of PTK2 rs7843014 
and rs7460 was carried out using real-time PCR in 96-well plates each containing a reaction volume of 
10 μL.  For DNA obtained from whole blood samples, the reaction volume contained 0.2 μL of 
participant DNA [9.9 ±1.1 ng, amounts determined using ~20% of participant DNA samples], 5 μL of 
TaqMan genotyping master mix (Applied Biosystems®, UK), 4.3 μL of nuclease-free H2O and 0.5 μL 
of TaqMan genotyping assay mix.  For DNA samples obtained from buccal cells, the 10 μL reaction 
volume contained 1 μL of participant DNA [18.6 ± 4.6 ng], 5 μL of TaqMan genotyping master mix, 
3.5 μL of nuclease-free H2O and 0.5 μL of TaqMan genotyping assay mix.  In control wells, nuclease-
free H2O replaced the DNA sample.   
 
The PCR plate was sealed (Microseal ‘B’ adhesive seal, Bio-Rad Laboratories, Hercules, CA) and DNA 
amplification (Chromo4 Real-Time PCR Detection System, Bio-Rad Laboratories) of each 
polymorphism was completed using the following PCR protocol: 10 min at 95°C followed by 40 cycles 
of denaturation for 15 s at 92°C, primer annealing and extension for 1 min at 60°C and plate read.  
Genotypes were determined by measurement of end-point fluorescence of VIC® and FAM® detected 
by the PCR machine and analysed using Opticon Monitor software (Bio-Rad Laboratories). For the 
rs7460 polymorphism the alleles indicated by VIC® and FAM® were converted and nucleotides were 
reported according to NCBI (http://www.ncbi.nlm.nih.gov/snp/?term=rs7460). All samples were 
analysed in duplicate and 100% agreement between all duplicate samples was achieved.   
10 
 
 
Statistical analysis 
The frequency of each polymorphism was assessed for compliance with Hardy-Weinberg equilibrium 
using X2 tests.  A one-way analysis of variance (ANOVA) was conducted to determine any significant 
differences in physical characteristics (height, mass, BMI and age) between genotypes.  Pearson’s 
correlations were used to identify variables that made a meaningful contribution to the variability of the 
muscle phenotype under investigation, and those identified were included as confounding variables in 
subsequent analyses of covariance (ANCOVA).  ANOVA, or where appropriate ANCOVA, was 
conducted to investigate genotype differences in muscle strength phenotypes and linear trend analyses 
were used to assess genotype associations with muscle strength phenotypes. Post-hoc pairwise 
comparisons were subjected to Benjamini-Hochberg corrections.  Where a tendency between genotype 
groups was observed (P between 0.05 and 0.10), the two genotype groups with most similar means 
were combined and compared using an independent samples t-test (Erskine et al. 2012).  Furthermore, 
the extent of linkage disequilibrium between PTK2 rs7843014 and rs7460 was determined using CubeX 
online software (http://www.oege.org/software/cubex) to estimate haplotype frequencies and calculate 
D’ and R2 as the difference between the observed and expected haplotype frequencies (Gaunt et al. 
2007).  Statistical analyses were performed using SPSS version 19.0 and alpha set at 0.05.  Data are 
presented as mean ± SD. 
 
Results 
Genotype frequencies for PTK2 rs7843014 (AA = 32.1%, AC = 49.1%, CC = 18.8%) and rs7460 (AA 
= 24.2%, AT = 50.0%, TT = 25.8%) were in Hardy-Weinberg equilibrium (X2 ≤ 1.661, P ≥ 0.436).  
There were no differences between genotypes of either SNP for height, mass, BMI or age (P ≥ 0.106; 
Table 1).  There were moderate correlations between muscle volume (r ≥ 0.361, P ≤ 4.7 x 10-4), PCSA 
(r ≥ 0.417, P ≤ 2.2 x 10-6) and all muscle strength phenotypes. Consequently, muscle volume was 
included as a covariate in analyses of MVCKE torque and net MVCKE torque but not specific force, as 
this is accounted for during the calculation of muscle specific force.   
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VL specific force tended to differ between genotype groups for PTK2 rs7843014 (P = 0.060) and rs7460 
(P = 0.089; Table 2).  VL specific force of rs7843014 AA homozygotes was 8.3% higher than C-allele 
carriers (P = 0.017; Fig. 1).  Similarly, rs7460 AA homozygotes had 5.4% higher VL specific force 
than T-allele carriers (P = 0.029; Fig. 1).  Linkage disequilibrium between the two SNPs was calculated 
as D’ = 0.894 and R2 = 0.591.  Thus, while individual contributions of rs7843014 and rs7460 to inter-
individual variability in VL specific force were 3.5% (P = 0.041) and 3.3% (P = 0.048), respectively, 
no more variability (3.8%, P = 0.107) could be accounted for by both SNPs together. 
 
Net MVCKE torque tended to differ between rs7843014 genotype groups (P = 0.094; Table 2), although 
there was no difference between AA homozygotes and C-allele carriers (P = 0.128).  However, there 
was a linear trend in net MVCKE torque of AA>AC>CC (P = 0.041, ηp2 = 0.042).  No differences in 
net MVCKE torque were observed between genotype groups for PTK2 rs7460 (P = 0.275), nor were 
there any genotype differences in MVCKE torque for either polymorphism (P ≥ 0.107; Table 2).  
Similarly, no differences in any architectural or size phenotypes were observed between genotype 
groups for either polymorphism (P ≥ 0.133; Table 2). 
 
Discussion 
The aim of this study was to investigate the relationship between polymorphisms in the PTK2 gene and 
muscle strength phenotypes in a healthy population. Genotype and allele frequencies for PTK2 
rs7843014 and rs7460 were similar to previous reports in Caucasian populations (Erskine et al. 2012), 
while mean MVCKE torque, net MVCKE torque and VL specific force in the current study (250 N∙m, 
274 N∙m and 21.4 N∙cm-2, respectively) were in accordance with previous reports in comparable 
populations (Narici et al. 1992; Erskine et al. 2012; Erskine et al. 2009).  We report a genotype-
phenotype association between each of the PTK2 SNPs and VL specific force. 
 
PTK2 is the gene encoding FAK, a protein integral to the formation and turnover of muscle costameres 
(Quach and Rando 2006).  During muscle contraction, muscle costamere complexes are involved in 
transmitting force laterally from the muscle contractile elements to the ECM (Bloch and Gonzalez-
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Serratos 2003).  Differing ability of muscle to transmit force laterally may translate into variability in 
maximal joint torque and/or muscle specific force.  In the current study, polymorphisms in the PTK2 
gene were associated with VL specific force but not MVCKE torque, net MVCKE torque, muscle 
architecture or size.  Individuals homozygous for the rs7843014 A-allele had greater VL specific force 
than their C-allele counterparts (8.3%), and those homozygous for the rs7460 A-allele demonstrated 
greater VL specific force than T-allele carriers (5.4%; Fig. 1).  When considering a previous study 
observed no differences in quadriceps femoris specific force between men, women, boys or girls 
(O'Brien et al. 2010) these genotype-group observations represent important differences.  Furthermore, 
the inter-individual variability observed within this phenotype was 16%, and together, the two PTK2 
SNPs explain a substantial proportion (~25%) of this variability.  A previous report on the influence of 
PTK2 rs7843014 and rs7460 on muscle strength also reported a significant association between 
quadriceps femoris muscle specific force and A-allele (rs7843014 and rs7460) homozygotes in a 
smaller Caucasian cohort (Erskine et al. 2012).  Thus, the current investigation provides the first 
independent replication of the findings from this previous smaller cohort study and together these 
findings demonstrate a probable association of PTK2 with muscle specific force. 
 
A plausible explanation for the findings of the current investigation may be that AA (rs7843014 and 
rs7460) homozygotes experience altered PTK2 expression compared to their C-allele (rs7843014) and 
T-allele (rs7460) carrying counterparts.  Interestingly, an association between CC (rs7843014) and TT 
(rs7460) genotypes and lower gene expression in Spanish Caucasians has been reported (Garatachea et 
al. 2014).  Furthermore, in vitro FAK-null cells demonstrate diminished integrin activation and a 
reduced adhesion-strengthening rate, which results in the formation of fewer integrin-ECM bonds, 
compared to cells expressing FAK (Michael et al. 2009).  Contrastingly, however, evidence exists 
reporting FAK-null cells actually form stronger adhesions, possess enhanced contractile properties and 
migrate slower than their wild-type counterparts (Ilic et al. 1995; Chen et al. 2002; Ren et al. 2000), 
thus demonstrating the complexity surrounding FAK-regulated adhesion strength and the role of PTK2 
in the variation within muscle specific force production.  Both  rs7843014 and rs7460 are in non-coding 
regions, and although it is unlikely that either the SNP would result in changes to the amino acid 
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sequence of FAK that would elicit comparable effects to those of FAK-null cells, potential alterations 
to the magnitude, location and timing of gene expression, or mRNA stability as a consequence of one 
or both of these SNPs cannot be discounted (Laguette et al. 2011; September et al. 2009). 
 
The observed association between the AA genotypes and enhanced VL specific force might be 
attributable to an increased costamere density as a consequence of more integrin-ECM bonds with 
higher gene expression (Bang et al. 2001), compared to T-allele (rs7460) and C-allele (rs7843014) 
carriers (Garatachea et al. 2014).  Although it remains unclear how an increased costamere density 
corresponds to an increase in specific force, it could be achieved via enhanced lateral transmission of 
force (Jones et al. 1989; Street 1983).  An increased costamere density is likely to result in more 
intermediate connections between the ECM, myofibres and aponeurosis, effectively splitting serial 
sarcomeres into numerous force-generating units whilst also reducing functional muscle fibre length 
(Jones et al., 1989).  Assuming all else is equal, it is hypothesized that more force-generating units 
within a fibre would reduce maximal shortening velocity whilst enabling a simultaneous increase in 
force generation within a given PCSA, thus resulting in increased muscle specific force (Jones et al. 
1989; Huijing 1999).  Whilst evidence to support this hypothesis is tenuous, Erskine et al. (2011) 
observed an increase in specific force but not power per unit of muscle mass following resistance 
training.  Given that maximal muscle power is the product of maximal shortening velocity, which is 
expected to reduce with an increased costamere density, and maximal force, which is expected to 
increase with an increased costamere density, when power is normalized to muscle volume it should 
remain unchanged despite an increase in specific force as a consequence of an increased costamere 
density.   As Erskine et al. (2011) did not determine maximal shortening velocity, it is unclear if their 
observed increase in specific force was inversely proportional to maximal shortening velocity and 
would explain why normalized power remained unchanged.  Future research is therefore necessary to 
include measurements of maximal shortening velocity alongside specific force and power, to confirm 
or refute this speculation.  Although the mechanism by which costamere density might contribute to 
enhanced lateral force transmission is currently undetermined, proposed mechanisms include the 
presence of a greater number of costameres per muscle fibre and/or a greater number of smaller fibres 
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per muscle and thus a higher fibre perimeter-to-area ratio (Erskine et al. 2012). If the latter were true, a 
muscle containing a greater number of smaller fibres could exhibit comparable muscle size and 
architecture to a muscle containing fewer larger fibres.  Accordingly, the data presented in Table 2 
revealed no associations between PTK2 genotype and any muscle architectural or size phenotypes, thus 
suggesting a greater number of smaller fibres may contribute to an increased costamere density.  Future 
research should investigate PTK2 genotype differences in muscle costamere density via direct 
measurement to confirm or refute this hypothesis.  
 
Further to specific force, we hypothesized that PTK2 genotype would be associated with MVCKE and 
net MVCKE torque, but no associations were observed.  It is possible that any genotype associations 
with these phenotypes were masked by inter-individual variability in other important determinants of 
torque, such as muscle size, architecture, activation capacity, co-activation and tendon moment arm 
length (Stebbings et al. 2014).  Indeed the inter-individual variability observed in these determinants 
within the current study ranged from 6% for muscle activation and co-activation capacity to ~20% for 
muscle architecture and size. 
 
Conclusion 
This study has identified an association between polymorphisms in the PTK2 gene and VL muscle 
specific force, thus providing an independent replication of previous research conducted on the 
quadriceps femoris muscle group (Erskine et al. 2012).  These findings extend our understanding of the 
influence of genetic variation on the intrinsic strength of a muscle and have potential implications for 
ageing populations for whom the maintenance of muscle specific force is important to promote 
independence and a better quality of life. 
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Table 1 Participant physical characteristics according to PTK2 genotype frequency for the rs7843014 and rs7460 polymorphisms.  Frequency data 
presented as count (%), all other data presented as mean ± SD. 
         rs7843014         rs7460  
 All AA AC CC P AA AT TT P 
Frequency (%) 120 (100) 42 (35) 52 (43) 26 (22)  34 (28) 54 (45) 32 (27)  
Age (yrs) 20.6 ± 2.3 20.4 ± 2.7 20.7 ± 2.3 20.8 ± 2.4 0.705 20.4 ± 2.3 20.8 ± 2.4  20.4 ± 2.2 0.623 
Height (m) 1.79 ± 0.06 1.78 ± 0.06 1.79 ± 0.07 1.79 ± 0.06 0.594 1.79 ± 0.07 1.80 ± 0.05 1.77 ± 0.07 0.217 
Mass (kg) 75.0 ± 10.0 72.9 ± 9.3 75.4 ± 10.4 77.4 ± 10.0 0.180 74.9 ± 11.0 76.8 ± 9.3 72.0 ± 9.7 0.106 
BMI (kg·m-2) 23.4 ± 2.7 23.0 ± 2.5 23.4 ± 2.7 24.1 ± 3.1 0.248 23.5 ± 3.0 23.7 ± 2.7 22.8 ± 2.5 0.326 
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Table 2 Muscle strength characteristics according to PTK2 rs7843014 and rs7460 genotype. 
        rs7843014         rs7460  
 AA AC CC P AA AT TT P 
VL fascicle length (cm) 7.2 ± 1.8 7.0 ± 1.4 7.5 ± 1.4 0.371 7.3 ± 1.4 7.1 ± 1.7 7.2 ± 1.7 0.844 
VL pennation angle (°) 19.2 ± 3.8 20.1 ± 4.0 18.5 ± 3.6 0.183 18.8 ± 3.1 20.2 ± 4.6 18.8 ± 3.0 0.133 
VL ACSA (cm2) 21.0 ± 2.4 21.6 ± 2.7 21.9 ± 2.2 0.351 21.6 ± 2.3 21.5 ± 2.6 21.1 ± 2.7  0.689 
VL PCSA (cm2) 71.3 ± 10.9 71.6 ± 13.6 72.7 ± 13.8 0.912 70.4 ± 15.0 72.3 ± 11.5 72.2 ± 12.3 0.768 
Peak MVCKE torque (N∙m) 260 ± 50.9 250 ± 43.0 243 ± 44.7 0.107 253 ± 51.7 250 ± 42.0 243 ± 45.9 0.495 
Net MVCKE torque (N∙m) 286 ± 53.0 272 ± 56.1 257 ± 46.2 0.094 276 ± 57.8 267 ± 53.8 259 ± 46.9 0.275 
VL Specific force (N∙cm-2) 22.3 ± 2.6 21.1 ± 2.6 21.1 ± 2.6 0.060 22.4 ± 2.8 21.3 ± 2.5 21.1 ± 2.6 0.089 
P denotes genotype group differences; VL, vastus lateralis; ACSA, anatomical cross-sectional area; PCSA, physiological cross-sectional area; MVCKE, 
maximal voluntary knee extension. 
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Fig. 1 Vastus lateralis specific force according to PTK2 rs7843014 and rs7460 genotype. rs7460 AA 
homozygotes (black bars) had higher specific force than T-allele carriers (white bars; *P = 0.029) and 
rs7843014 AA homozygotes (black bars) had higher specific force than C-allele carriers (white bars; 
‡P = 0.017).  Data are mean ± SD 
